Refine by
Applications
- Potential Functional Cures for Patients with Chronic Diseases
- Shielded Living Therapeutics Cell for Lysosomal Diseases
- Shielded Living Therapeutics Cell for Diabetes
- Shielded Living Therapeutics Cell for Rare Blood Disorders
- Pipeline for Infectious Diseases
- Pipeline for Immuno-Oncology
- Pipeline for Precision Medicine
Protein Therapeutic Equipment & Supplies
39 equipment items found
Manufactured by:Evox Therapeutics Limited based inOxford, UNITED KINGDOM
Evox’s proprietary protein engineering technology enables loading of protein therapeutics and tissue targeting moieties onto the surfaces of exosomes, which allows targeting and display of therapeutic proteins to an organ of ...
Manufactured by:PsiOxus Therapeutics Ltd. based inAbingdon, UNITED KINGDOM
Three transgenes: Producing IL-12, IL-15 and a chemokine. As part of our expanding T-SIGn platform pipeline, this candidate is progressing through its IND enabling activities in readiness for entering clinical ...
Manufactured by:PsiOxus Therapeutics Ltd. based inAbingdon, UNITED KINGDOM
Novel transgene combinations. Our research team are developing a suite of viral vectors with new and innovative transgene ...
Manufactured by:PsiOxus Therapeutics Ltd. based inAbingdon, UNITED KINGDOM
Two transgenes: Producing a secreted CD40 agonist monoclonal antibody. Currently in clinical trials in the US and UK. ...
Manufactured by:PsiOxus Therapeutics Ltd. based inAbingdon, UNITED KINGDOM
Three transgenes: Producing membrane bound CD80 and secreted MIP1α and IFNa. As part of our expanding T-SIGn platform pipeline, this candidate is progressing through its IND enabling activities in readiness for entering clinical ...
Manufactured by:PsiOxus Therapeutics Ltd. based inAbingdon, UNITED KINGDOM
Four transgenes: Producing an anti-FAP bispecific plus cytokines/chemokines. Currently in clinical trials in the US and UK. See our clinical trials page for more information. The aim of this study is to characterise the safety, tolerability and preliminary efficacy of NG-641 in patients with metastatic or advanced epithelial ...
Manufactured by:Aptevo Therapeutics based inSeattle, WASHINGTON (USA)
ADAPTIR-FLEX technology extends advantages of ADAPTIR technology to create protein therapeutics with varied specificity and valency and potentially new modes of ...
by:Ainovo Biotech Inc. based inSacramento, CALIFORNIA (USA)
AIGenus leverages deep learning algorithms, high performance computing, and biophysical simulations to custom design highly-specific, patentable - proteins for therapeutic and diagnostic purposes. It's protein generation, driven by cutting-edge Machine ...
Manufactured by:OPKO Health, Inc. based inMiami, FLORIDA (USA)
Our Carboxyl Terminal Peptide (CTP) technology is used to extend the half-lives of pharmacologically active proteins. CTP uses recombinant technology to fuse a short, naturally occurring 28 amino acid sequence (a CTP) to a pharmacologically active protein which results in slower excretion of the therapeutic protein, thus, ...
by:Theradaptive based inFrederick, MARYLAND (USA)
With our innovative protein-engineering technology, we transform proteins into material-binding ...
by:Eli Lilly and Company based inIndianapolis, INDIANA (USA)
Our Shielded Living Therapeutics platform combines advanced cell engineering with innovations in biocompatible materials, potentially enabling our products to produce a wide range of therapeutic molecules that may be missing or deficient in the body, including proteins, enzymes or other therapeutic ...
Manufactured by:ASC Therapeutics based inMilpitas, CALIFORNIA (USA)
Genome editing technologies enables permanent modifications to the genome by harnessing the activities of certain enzymes (e.g. nucleases and integrase) and invoking DNA repair mechanisms at specific locations in the genome. As a therapeutic modality, genome editing can correct a defective gene, disrupt a deleterious gene, or target a therapeutic gene to a ...
Manufactured by:Confo Therapeutics based inGhent/Zwijnaarde, BELGIUM
With its unique antibody-based technology, Confo Therapeutics aims to overcome the current limitations of GPCR drug discovery in order to fully realize the potential of GPCRs as drug ...
Manufactured by:Bayer AG based inLeverkusen, GERMANY
Small molecules (SMOLs) have long been in the focus of modern medicine. Over the last century, their advent revolutionized healthcare and improved the lives of patients all over the world. Most of today´s SMOLs exert their function by binding to proteins, thereby modulating their ability to catalyze biochemical reactions. However, a lot of proteins are difficult targets for SMOLs, since ...
Manufactured by:Evox Therapeutics Limited based inOxford, UNITED KINGDOM
The Evox portfolio includes granted and pending applications in the world's major pharmaceutical markets, including USA, Europe, Japan, China as well as various other jurisdictions. In addition to the patent portfolio Evox also safeguards its intellectual property by the maintenance of several trademarks, copyrights, and trade secrets which together form broad and deep protection for the ...
Manufactured by:Rocket Pharmaceuticals, Inc. based inCranbury, NEW JERSEY (USA)
The process involves collection and isolation of a patient’s hematopoietic stem cells (HSCs), insertion of the corrected gene into the HSCs via a lentiviral vector outside the body, and the infusion of modified HSCs back into the patient. The goal is to enable sufficient quantities of a healthy, disease-modifying therapeutic protein to be manufactured by ...
Manufactured by:Rocket Pharmaceuticals, Inc. based inCranbury, NEW JERSEY (USA)
The process involves collection and isolation of a patient’s hematopoietic stem cells (HSCs), insertion of the corrected gene into the HSCs via a lentiviral vector outside the body, and the infusion of modified HSCs back into the patient. The goal is to enable sufficient quantities of a healthy, disease-modifying therapeutic protein to be manufactured by ...
by:Sutro Biopharma Inc. based inSouth San Francisco, CALIFORNIA (USA)
Conventional methods for expressing proteins utilize cell lines originating from bacteria, yeast, insects, plants, or mammals. Because these methods require intact, functioning cells, the biochemical and biophysical parameters under which proteins are produced using these methods are inherently limited, often failing to produce many proteins and ...
Manufactured by:Solarvest BioEnergy Inc. based inSummerville, PRINCE EDWARD ISLAND (CANADA)
The Company has promising laboratory results in hand for our first mid-term target, the expression of therapeutic proteins in algae. The company has used its proprietary technology to produce the highest published amounts of therapeutic proteins from algae, and is using this technology to produce Bone Morphogenetic ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
We design and manufacture therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry because of the astonishingly high cost of traditional methods. Now, for the first time, Lumen can make antibodies and other biologics at a cost that allows for daily, high-dose, oral and topical delivery. Our current programs target markets that are enormous, the treatment ...